Security Snapshot

Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) Institutional Ownership

CUSIP: 71377E105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

6

Price

$7.67

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock - $0.0001 par value
Symbol
PHLT
Shares outstanding
80,439,690
Price per share
$7.75
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6
Total reported value
$46
Share change
-78,711,169
Value change
-$608,440,150
Number of holders
1
Price from insider filings
$7.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PHLT - Performant Healthcare Inc - Common Stock - $0.0001 par value is tracked under CUSIP 71377E105.
  • 1 institution reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1 to 0 between Q4 2025 and Q1 2026.
  • Reported value moved from $46 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 71377E105?
CUSIP 71377E105 identifies PHLT - Performant Healthcare Inc - Common Stock - $0.0001 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 16% $53,117,291 12,923,915 Mathew P. Arens 30 Jun 2025
GLAZER CAPITAL, LLC 8.4% +43% $52,231,100 +$16,704,515 6,756,934 +47% Glazer Capital, LLC 30 Sep 2025
VANGUARD GROUP INC 4.9% -1.2% $30,734,503 +$425,761 3,976,003 +1.4% The Vanguard Group 30 Sep 2025

As of 31 Dec 2025, 1 institutional investors reported holding 6 shares of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT). This represents 0% of the company’s total 80,439,690 outstanding shares.

Institutional Holders of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 0 $0 -$46 $7.75 0
2025 Q4 6 $46 -$608,440,150 $7.67 1
2025 Q3 78,721,439 $608,519,537 +$123,838,446 $7.73 117
2025 Q2 68,135,578 $272,546,030 +$9,576,367 $4.00 84
2025 Q1 66,391,280 $196,521,963 +$862,347 $2.96 79
2024 Q4 66,086,004 $199,583,051 +$1,881,715 $3.02 75
2024 Q3 58,891,734 $220,253,383 +$3,236,368 $3.74 76
2024 Q2 57,729,700 $167,416,363 +$898,456 $2.90 68
2024 Q1 57,367,911 $168,598,709 +$1,191,127 $2.94 73
2023 Q4 56,862,123 $177,545,533 +$8,021,780 $3.12 73
2023 Q3 54,619,896 $123,442,190 +$2,512,035 $2.26 70
2023 Q2 53,445,642 $144,302,176 +$1,174,542 $2.70 70
2023 Q1 51,730,311 $175,878,839 +$11,544,440 $3.40 64
2022 Q4 48,258,458 $174,215,043 +$12,211,816 $3.61 51
2022 Q3 44,632,732 $82,571,000 -$368,756 $1.85 37
2022 Q2 45,204,609 $118,919,000 +$5,177,253 $2.63 43
2022 Q1 43,207,970 $134,379,000 +$4,992,794 $3.11 45
2021 Q4 41,733,357 $100,581,000 -$9,633,959 $2.41 43
2021 Q3 42,356,731 $167,667,000 +$58,452,742 $3.96 53
2021 Q2 27,590,480 $103,464,000 +$20,611,909 $3.75 34
2021 Q1 22,210,066 $47,752,000 +$3,620,667 $2.15 24
2020 Q4 20,543,050 $18,098,000 -$8,245,748 $0.88 19
2020 Q3 25,756,542 $24,174,000 -$205,746 $0.94 17
2020 Q2 25,985,872 $16,984,000 -$325,003 $0.66 17
2020 Q1 26,486,063 $23,784,000 -$745,427 $0.90 19
2019 Q4 26,717,491 $27,249,000 +$244,618 $1.02 20
2019 Q3 30,277,600 $33,305,000 -$22,377 $1.10 26
2019 Q2 30,297,631 $31,815,000 -$2,577,291 $1.05 23
2019 Q1 30,324,897 $62,770,000 -$658,537 $2.07 26
2018 Q4 30,612,343 $68,879,000 +$910,840 $2.25 26
2018 Q3 30,210,193 $63,329,000 -$166,030 $2.05 27
2018 Q2 30,256,712 $65,050,000 -$1,876,561 $2.15 29
2018 Q1 30,163,017 $90,491,000 +$544,317 $3.00 36
2017 Q4 30,016,598 $49,526,000 -$10,495 $1.65 30
2017 Q3 27,761,174 $50,521,000 -$32,554 $1.82 31
2017 Q2 27,771,598 $58,039,000 +$581,746 $2.09 35
2017 Q1 27,494,822 $80,563,000 +$215,899 $2.93 37
2016 Q4 27,617,532 $64,900,000 +$440,399 $2.35 44
2016 Q3 26,755,472 $78,929,000 -$1,942,466 $2.95 38
2016 Q2 28,280,490 $45,805,706 -$1,237,825 $1.62 39
2016 Q1 29,012,129 $49,317,415 -$402,589 $1.70 47
2015 Q4 29,143,158 $52,137,000 -$4,192,302 $1.79 44
2015 Q3 30,880,849 $74,711,000 -$2,287,708 $2.42 48
2015 Q2 31,488,571 $101,991,000 -$6,601,877 $3.24 60
2015 Q1 33,049,349 $112,298,738 -$6,993,885 $3.40 78
2014 Q4 32,919,891 $218,696,804 +$2,374,732 $6.65 87
2014 Q3 31,964,859 $258,515,690 +$10,263,678 $8.08 86
2014 Q2 29,394,110 $296,812,980 +$10,103,170 $10.10 87
2014 Q1 28,430,174 $257,220,135 +$6,759,266 $9.05 78
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .